The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-(Azetidin-1-ylmethyl)benzyl)-2-methylpyrazolo[1,5-a]-pyrimidine-6-carboxamide ID: ALA4846847
PubChem CID: 164608758
Max Phase: Preclinical
Molecular Formula: C19H21N5O
Molecular Weight: 335.41
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc2ncc(C(=O)NCc3ccc(CN4CCC4)cc3)cn2n1
Standard InChI: InChI=1S/C19H21N5O/c1-14-9-18-20-11-17(13-24(18)22-14)19(25)21-10-15-3-5-16(6-4-15)12-23-7-2-8-23/h3-6,9,11,13H,2,7-8,10,12H2,1H3,(H,21,25)
Standard InChI Key: GMGNUYYIYPRMEB-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
12.0611 -5.9907 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.0611 -6.8079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7660 -7.2165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4751 -6.8079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1842 -7.2165 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.9573 -6.9618 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.4416 -7.6251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9573 -8.2842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1842 -8.0336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4751 -8.4422 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.7660 -8.0337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2588 -7.6251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3520 -7.2165 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.6429 -6.8079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9379 -7.2165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9379 -8.0336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2288 -8.4422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5197 -8.0336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8148 -8.4422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1057 -8.0336 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3183 -8.2427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1051 -7.4553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8925 -7.2421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5197 -7.2165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2288 -6.8079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
5 9 1 0
9 10 1 0
10 11 2 0
3 11 1 0
7 12 1 0
2 13 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
20 23 1 0
18 24 1 0
24 25 2 0
15 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 335.41Molecular Weight (Monoisotopic): 335.1746AlogP: 2.17#Rotatable Bonds: 5Polar Surface Area: 62.53Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.27CX Basic pKa: 8.36CX LogP: 1.41CX LogD: 0.41Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.78Np Likeness Score: -2.17
References 1. Ma XR, Xu L, Xu S, Klein BJ, Wang H, Das S, Li K, Yang KS, Sohail S, Chapman A, Kutateladze TG, Shi X, Liu WR, Wen H.. (2021) Discovery of Selective Small-Molecule Inhibitors for the ENL YEATS Domain., 64 (15.0): [PMID:34279931 ] [10.1021/acs.jmedchem.1c00367 ]